Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua F Coleman

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Archives of Pathology & Laboratory Medicine|November 7, 2023
Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)Diane Wilcock, Deepika Sirohi, Daniel Albertson, et al.
American Journal of Clinical Pathology|December 10, 2022
Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle TumorsValarie McMurtry, Jonathan Mahlow, Joshua F Coleman, et al.
International Journal of Surgical Pathology|March 9, 2022
Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic NeoplasmsDiane M Wilcock, Valarie McMurtry, Joshua F Coleman, et al.
International Journal of Environmental Research and Public Health|November 27, 2025
Instability in the Penta-C and Penta-D Loci in Microsatellite-Unstable Endometrial CancerAhmet Yilmaz, Wendy L Frankel, Weiqiang Zhao, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Instability in Pentanucleotide Markers in a Subset of Microsatellite Instability-High Colorectal CancerAhmet Yilmaz, Wendy L Frankel, Benjamin J Swanson, et al.
The Journal of Molecular Diagnostics : JMD|October 16, 2022
Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American PathologistsEric J Duncavage, Joshua F Coleman, Monica E de Baca, et al.
American Journal of Clinical Pathology|February 12, 2025
HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistryDiane Wilcock, Deepika Sirohi, Joshua F Coleman, et al.
Electrophoresis|April 18, 2009
Quantitative proteomics investigation of pancreatic intraepithelial neoplasiaSheng Pan, Ru Chen, Beth Ann Reimel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 27, 2025
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ HybridizationCameron Beech, Diane M Wilcock, Kristina H Moore, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2023
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast CancerDiane M Wilcock, Kristina H Moore, Leslie Rowe, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Archives of Pathology & Laboratory Medicine|November 7, 2023
Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0)Diane Wilcock, Deepika Sirohi, Daniel Albertson, et al.
American Journal of Clinical Pathology|December 10, 2022
Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle TumorsValarie McMurtry, Jonathan Mahlow, Joshua F Coleman, et al.
International Journal of Surgical Pathology|March 9, 2022
Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic NeoplasmsDiane M Wilcock, Valarie McMurtry, Joshua F Coleman, et al.
International Journal of Environmental Research and Public Health|November 27, 2025
Instability in the Penta-C and Penta-D Loci in Microsatellite-Unstable Endometrial CancerAhmet Yilmaz, Wendy L Frankel, Weiqiang Zhao, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Instability in Pentanucleotide Markers in a Subset of Microsatellite Instability-High Colorectal CancerAhmet Yilmaz, Wendy L Frankel, Benjamin J Swanson, et al.
The Journal of Molecular Diagnostics : JMD|October 16, 2022
Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American PathologistsEric J Duncavage, Joshua F Coleman, Monica E de Baca, et al.
American Journal of Clinical Pathology|February 12, 2025
HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistryDiane Wilcock, Deepika Sirohi, Joshua F Coleman, et al.
Electrophoresis|April 18, 2009
Quantitative proteomics investigation of pancreatic intraepithelial neoplasiaSheng Pan, Ru Chen, Beth Ann Reimel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 27, 2025
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ HybridizationCameron Beech, Diane M Wilcock, Kristina H Moore, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2023
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast CancerDiane M Wilcock, Kristina H Moore, Leslie Rowe, et al.
Pageof 3